Lung disease Archives

News and Trends 23 May 2023

Vicore reports new data from idiopathic pulmonary fibrosis study

Vicore Pharma Holding AB (publ), has announced an updated interim analysis of its AIR phase 2a trial with C21 in idiopathic pulmonary fibrosis (IPF). With 51 patients enrolled, the data…

May 23, 2023 - 4 minutesmins - By Jim Cornall

Interview 2 May 2023

Generative AI in novel drug development

Within months of its release, ChatGPT is finding use in almost all industries, including biotech, pharma, and healthcare. ChatGPT and other large language models like it belong to a family…

May 2, 2023 - 4 minutesmins - By Sachin Rawat

News and Trends 17 Apr 2023

Aer Therapeutics raises $36M to tackle lung diseases

Aer Therapeutics, a joint University College Dublin (UCD) and University of California, San Francisco (UCSF) biopharmaceutical spin-out company developing novel inhaled treatments for muco-obstructive lung diseases, has announced the closing…

April 17, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 16 Mar 2023

Inspire Biotherapeutics launches to target lung diseases through gene therapy

Inspire Biotherapeutics Inc., an emerging Canadian biotech company with a mission to create gene therapies for monogenic and acquired diseases of the lung, is set to move its novel lung…

March 16, 2023 - 2 minutesmins - By Jim Cornall

COPD lung disease chronic obstructive pulmonary disease

News and Trends 20 Dec 2022

Verona Pharma drug meets COPD phase 3 trial endpoints

Verona Pharma plc has announced positive results of its phase 3 ENHANCE-1 trial evaluating nebulized ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease (COPD). The ENHANCE-1 trial successfully…

December 20, 2022 - 2 minutesmins - By Jim Cornall

More News! 8 Dec 2022

Enhertu’s positive results demonstrate improvement in overall survival

Enhertu, an antibody drug conjugate, being jointly developed by Daiichi Sankyo and AstraZeneca, has demonstrated a statistically significant and clinically meaningful improvement in overall survival. Updated results from DESTINY-Breast03 phase…

December 8, 2022 - 4 minutesmins - By Liza Laws

News and Trends 17 Oct 2022

More positive news announced for Verona’s COPD treatment

Clinical-stage biopharmaceutical company, Verona, has announced more positive news from its phase 3 ENHANCE-2 clinical trial of ensifentrine that treats chronic obstructive pulmonary disease (COPD). The company focuses on respiratory…

October 17, 2022 - 3 minutesmins - By Liza Laws

News and Trends 3 Oct 2022

Redx presents data confirming anti-fibrotic effects of lung disease drug

Redx Pharma has announced preclinical efficacy data in immune mediated models for RXC007. The data on RXC007, its lead fibrosis asset, was presented alongside encouraging final phase 1 safety and…

October 3, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 5 Sep 2022

Sanofi and Regeneron’s Dupixent shows sustained improvement in lung function in children

A maintenance therapy from Sanofi and Regeneron, added to other asthma medications, has shown sustained improvement in lung function, low-rate of asthma attacks and a consistent safety profile for up…

September 5, 2022 - 3 minutesmins - By Liza Laws

acute respiratory distress syndrome pantherna therpeutics inflammatory lung disease

News and Trends 31 Aug 2022

Regulatory approval given to Iceland’s EpiEndo for study of COPD treatment

A treatment for chronic respiratory disorders will be the subject of a clinical trial in Iceland after regulatory and ethics approval was granted. EpiEndo Pharmaceuticals will start a clinical trial…

August 31, 2022 - 2 minutesmins - By Liza Laws

News and Trends 24 Aug 2022

Vocal biomarker agreement set to benefit patients with COPD in India

A new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease (COPD) in India is being developed after a multi-year agreement was signed. The agreement between Sonde Health, a…

August 24, 2022 - 3 minutesmins - By Liza Laws

PAN-TB collaboration: a new project for tuberculosis treatment

More News! 18 Aug 2022

Collaboration to advance investigational tuberculosis drug treatments

A collaboration called The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) was announced yesterday (August 17). The joint development agreement (JDA) will support the progression of two investigational tuberculosis…

August 18, 2022 - 5 minutesmins - By Liza Laws

News and Trends 8 Aug 2022

Lung cancer trial patients responding well to combination treatment offered by HUTCHMED and AstraZeneca

A medication used to treat non-small cell lung carcinomas (NSCLC) with specific mutations has demonstrated a 49% objective response rate (ORR) in patients. AstraZeneca and HUTCHMED announced that TAGRISSO Plus…

August 8, 2022 - 3 minutesmins - By Liza Laws

coronavirus COVID 19 Europe biotech lungs

News and Trends 21 Jul 2022

Additional funding for trial to study drug targeting lung immunity in elderly patients

Lung immunity in the elderly will be the subject of a controlled clinical trial after receiving clearance to go ahead from Health Canada. Qu Biologics will receive additional funding to…

July 21, 2022 - 3 minutesmins - By Liza Laws

lig biowise diagnostics antimicrobial resistance

News and Trends 7 Jul 2022

Treatments set to improve for lethal lung disease and ulcers following drug synergy data revelation

New data has been published today (July 7) evidencing findings that could lead to better treatment for people with lethal lung infections and infected diabetic foot ulcers caused by antimicrobial…

July 7, 2022 - 4 minutesmins - By Liza Laws

News and Trends 28 Jun 2022

Companies unite to bolster diagnostics for cancer and liver disease

Two companies set on making improvements for those with lung cancer, non-alcoholic fatty liver disease and breast cancer have partnered in a bid to bolster noninvasive diagnostics for the conditions.…

June 28, 2022 - 2 minutesmins - By Liza Laws

News and Trends 8 Jun 2022

United Therapeutics creates 3D printed lung scaffold

United Therapeutics Corporation said it has – in partnership with 3D Systems Corporation – produced the world’s most complex 3D-printed object, a human lung scaffold. The human lung scaffold was…

June 8, 2022 - 3 minutesmins - By Jim Cornall

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering